Our results provide novel insights of BA as a promising molecular inhibitor of breast cancer metastasis via glycolysis inhibition and also reveal a novel regulatory pathway between GRP78 and glycolytic metabolism in cancer cells. Here, HSPA5 is linked to breast carcinoma.